Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients after cyclosporin-treated corneal grafting
- PMID: 2214611
- DOI: 10.1007/BF01662784
Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients after cyclosporin-treated corneal grafting
Abstract
Allograft rejection occurs in up to 70% of high-risk keratoplasty patients. For this reason short-term Cyclosporin treatment was administered for three months to prevent graft loss. Of 23 renal healthy patients, 19 enjoyed long-term graft acceptance. We evaluated in these patients N-acetyl-beta-D-glucosaminidase (NAG) excretion as a marker of renal tubular damage. All patients, except one, showed urinary NAG excretion to be within the normal range. From this we conclude that no renal tubular damage occurs after short-term Cyclosporin treatment.
Similar articles
-
Urinary excretion of lysozyme and N-acetyl-beta-D-glucosaminidase in the diagnosis of renal allograft rejection.Ann Clin Biochem. 1978 Sep;15(5):253-60. doi: 10.1177/000456327801500161. Ann Clin Biochem. 1978. PMID: 363032
-
Urinary N-acetyl-beta-D-glucosaminidase and neopterin aid in the diagnosis of rejection and acute tubular necrosis in initially nonfunctioning kidney grafts.Nephron. 2000 Mar;84(3):228-35. doi: 10.1159/000045582. Nephron. 2000. PMID: 10720893
-
Reduced renal allograft survival is related to low urinary N-acetyl-beta-D-glucosaminidase excretion during the first posttransplant month.Transplantation. 1996 Feb 15;61(3):388-92. doi: 10.1097/00007890-199602150-00011. Transplantation. 1996. PMID: 8610347
-
The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment.Acta Medica (Hradec Kralove). 2005;48(2):75-80. Acta Medica (Hradec Kralove). 2005. PMID: 16259316 Review.
-
[N-acetyl-beta-D-glucosaminidase].Nihon Rinsho. 1995 May;53(5):1267-76. Nihon Rinsho. 1995. PMID: 7602790 Review. Japanese.